Skip to content

Study of Zhuang medicated thread moxibustion for patients with Mild Cognitive Impairment based on Traditional Chinese Medicine constitution

Study of Zhuang medicated thread moxibustion for patients with Mild Cognitive Impairment based on Traditional Chinese Medicine constitution

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300075486
Enrollment
Unknown
Registered
2023-09-06
Start date
2022-09-01
Completion date
Unknown
Last updated
2023-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild Cognitive Impairment based on Traditional Chinese Medicine constitution

Interventions

Experimental group:Zhuang medicated thread moxibustion
Waiting control group:In the first 6 months, no other intervention treatment was received
After 6 months, according to the patient s request, the same Zhuang medicated thread moxibustion as the experimental group was given.

Sponsors

First Affiliated Hospital, Guangxi University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
55 Years to 75 Years

Inclusion criteria

Inclusion criteria: ?Patients fulfilling diagnostic criteria for Mild Cognitive Impairment; ?Memory impairment (self-reported and confirmed by an informed person) with an MMSE score between 22 and 27;? Yang deficiency, blood stasis, or phlegm dampness meeting the criteria of the Classification and Determination of Physical Qualities in Traditional Chinese Medicine; ?Age between 55-75 years; ? Relatively normal or mildly impaired cognitive functions other than memory; ?Daily living ability and social occupation remain unaffected; ?Memory impairment did not meet the diagnostic criteria for dementia; ?Exclusion of any systemic diseases potentially causing brain dysfunction; (9) Informed consent signed by the subject or guardian.

Exclusion criteria

Exclusion criteria: ?Those with advanced, severe, or unstable comorbidities, such as liver or kidney disease, or other serious underlying medical conditions. ?Individuals with profound hearing or visual impairment who are unable to cooperate with the assessment. ?Those with active epilepsy. ? Individuals with a history of psychiatric disorders. ?Those with dementia, cerebral infarction, or any neurological or psychiatric disorder that may impact cognitive function.?Individuals who have been previously prescribed medications that may affect cognitive function or vital organs, such as the heart, brain, or kidneys. ?Individuals under 55 or over 75 years old.

Design outcomes

Primary

MeasureTime frame
Mini-mental state examination(MMSE);Montreal cognitive assessment(MoCA);auditory verbal learning test-Huashan version (AVLT-H);Animal fluency test ( AFT);Boston Naming Test(BNT);Shape trails test A(STT-A)/shape trails test B(STT-B);Functional Activities Questionnaire(FAQ);

Secondary

MeasureTime frame
Pittsburgh sleep quality index(PSQI);

Countries

China

Contacts

Public ContactZhao Li hua

First Affiliated Hospital, Guangxi University of Chinese Medicine

zhaolh@163.com+86 130 0691 3108

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026